Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 23% ± 4% | |
basal cell | 4 studies | 20% ± 5% | |
microglial cell | 4 studies | 29% ± 21% | |
pericyte | 4 studies | 25% ± 9% | |
T follicular helper cell | 3 studies | 27% ± 6% |
Insufficient scRNA-seq data for expression of CH25H at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1240.33 | 571 / 578 | 83% | 21.31 | 964 / 1155 |
brain | 65% | 245.50 | 1724 / 2642 | 90% | 32.84 | 636 / 705 |
intestine | 79% | 290.23 | 767 / 966 | 75% | 8.44 | 397 / 527 |
stomach | 79% | 343.17 | 285 / 359 | 72% | 7.97 | 205 / 286 |
esophagus | 91% | 592.94 | 1315 / 1445 | 57% | 10.49 | 105 / 183 |
breast | 89% | 543.29 | 407 / 459 | 56% | 5.12 | 630 / 1118 |
prostate | 78% | 275.96 | 191 / 245 | 65% | 6.42 | 328 / 502 |
bladder | 81% | 409.71 | 17 / 21 | 62% | 7.40 | 310 / 504 |
thymus | 69% | 215.01 | 452 / 653 | 69% | 13.15 | 416 / 605 |
adrenal gland | 88% | 334.61 | 226 / 258 | 40% | 4.46 | 93 / 230 |
pancreas | 24% | 45.61 | 80 / 328 | 87% | 12.82 | 154 / 178 |
uterus | 42% | 88.03 | 72 / 170 | 54% | 8.02 | 246 / 459 |
skin | 58% | 149.47 | 1056 / 1809 | 35% | 3.73 | 165 / 472 |
adipose | 88% | 862.28 | 1060 / 1204 | 0% | 0 | 0 / 0 |
kidney | 52% | 142.75 | 46 / 89 | 29% | 1.97 | 262 / 901 |
ovary | 49% | 136.02 | 89 / 180 | 30% | 2.11 | 131 / 430 |
tonsil | 0% | 0 | 0 / 0 | 67% | 7.08 | 30 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.16 | 17 / 29 |
liver | 35% | 82.82 | 78 / 226 | 24% | 3.35 | 97 / 406 |
blood vessel | 58% | 214.14 | 774 / 1335 | 0% | 0 | 0 / 0 |
spleen | 52% | 110.87 | 126 / 241 | 0% | 0 | 0 / 0 |
heart | 51% | 167.02 | 440 / 861 | 0% | 0 | 0 / 0 |
muscle | 23% | 54.39 | 183 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 1.44 | 9 / 80 |
peripheral blood | 1% | 5.90 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_1903914 | Biological process | negative regulation of fusion of virus membrane with host plasma membrane |
GO_0035754 | Biological process | B cell chemotaxis |
GO_0016126 | Biological process | sterol biosynthetic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0034340 | Biological process | response to type I interferon |
GO_0090206 | Biological process | negative regulation of cholesterol metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005506 | Molecular function | iron ion binding |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0000254 | Molecular function | C-4 methylsterol oxidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0001567 | Molecular function | cholesterol 25-hydroxylase activity |
Gene name | CH25H |
Protein name | Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH) |
Synonyms | |
Description | FUNCTION: Catalyzes the formation of 25-hydroxycholesterol from cholesterol, leading to repress cholesterol biosynthetic enzymes . Plays a key role in cell positioning and movement in lymphoid tissues: 25-hydroxycholesterol is an intermediate in biosynthesis of 7-alpha,25-dihydroxycholesterol (7-alpha,25-OHC), an oxysterol that acts as a ligand for the G protein-coupled receptor GPR183/EBI2, a chemotactic receptor for a number of lymphoid cells (By similarity). May play an important role in regulating lipid metabolism by synthesizing a corepressor that blocks sterol regulatory element binding protein (SREBP) processing . As an interferon-stimulated gene, has broad antiviral activities against a wide range of enveloped viruses, such as vesicular stomatitis virus (VSV) and SARS coronavirus-2 (SARS-CoV-2). Its product, 25-hydroxycholesterol, activates the ER-localized enzyme ACAT to induce internalization of accessible cholesterol on the plasma membrane and restricts SARS-CoV-2 S protein-mediated fusion which inhibits virus replication . In testis, production of 25-hydroxycholesterol by macrophages plays a role in Leydig cell differentiation (By similarity). Required to restrain inflammation in macrophages: production of 25-hydroxycholesterol protects macrophages from cholesterol overload, thereby preventing mitochondrial DNA release and subsequent activation of the AIM2 inflammasome (By similarity). . |
Accessions | O95992 ENST00000371852.4 |